MyFinsight
Home
About
Contact
allo: the income statement
Download
Download image
Net comprehensive
loss
-$41,120K
(37.08%↑ Y/Y)
Net unrealized gain
(loss) on...
$280K
(-70.12%↓ Y/Y)
Interest and other
income, net
$3,926K
(-41.45%↓ Y/Y)
Net loss
-$41,400K
(37.55%↑ Y/Y)
Total other income
(expense), net
$3,501K
(-36.12%↓ Y/Y)
Other income
(expenses), net
-$81K
(92.79%↑ Y/Y)
Interest expense
$344K
(244.00%↑ Y/Y)
Loss from operations
-$44,901K
(37.44%↑ Y/Y)
Total operating
expenses
$44,901K
(-37.44%↓ Y/Y)
General and
administrative
$13,737K
(-15.89%↓ Y/Y)
Research and development
$31,164K
(-30.30%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO)